Additionally, a recent review has combined mutational rates from several other Saudi hospitals, showing 0.4%–2.5% rate for BRAF, 28.6%–56% in KRAS, and 2%–2.2% in NRAS (Alfahed, 2023) Our understanding of the mutational landscape of CRC in the Saudi population is lacking, and the percentage of common somatic mutations reported from Saudi hospitals is sparse. This evidence concerns the gene BRAF and colorectal carcinoma.